Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Active Surveillance vs Adjuvant Chemoradiotherapy for Locally Resected Intermediate-Risk T1 Rectal Cancer: Multicentre Randomised Controlled Trial

NCT07669298 is registered in ClinicalTrials.gov with Medical University of Gdansk as lead sponsor.

NCT NCT07669298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07669298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Active Surveillance vs Adjuvant Chemoradiotherapy for Locally Resected Intermediate-Risk T1 Rectal Cancer: Multicentre Randomised Controlled Trial
Lead sponsor
Medical University of Gdansk
Phase
Not applicable
Overall status
Recruiting
Start date
June 14, 2026
Completion date
June 30, 2037
Enrollment
480 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer